BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- CONMED Corporation
- Study ID
- NCT06948591
- Status
- Recruiting
Conditions
- ACL Tears
Eligibility Criteria
- Sex
- ALL
- Age
- 14 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Anterior cruciate ligament reconstruction with BioBrace® augmentation — DEVICEAn arthroscopic anterior cruciate ligament reconstruction (ACLR) will be performed and the tissue graft will be augmented with the BioBrace® Reinforced Implant. BioBrace® is intended for use in surgical procedures for reinforcement of soft tissue where weakness exists. It is a bioresorbable, biocomposite scaffold composed of a highly porous collagen sponge and reinforced with poly-L-lactic-acid (PLLA). When used in ACLRs, it is sutured alongside the tissue graft to augment and reinforce the graft construct. BioBrace® is designed to mechanically and biologically augment weakened or torn soft tissue and can be integrated into surgeons' standard of care ACL reconstruction techniques.
- Arthroscopic anterior cruciate ligament reconstruction — PROCEDUREAn arthroscopic anterior cruciate ligament reconstruction is performed using standard surgical procedure.
Study Details
This research study will evaluate mid-term clinical safety and performance outcomes of the BioBrace® Reinforced Implant when used to augment a tissue graft during anterior cruciate ligament (ACL) reconstruction.
Key Dates
- Start date
- Apr 8, 2025
- Status verified
- Apr 2025
- Primary completion
- Jun 30, 2030
- Completion
- Jun 30, 2030
Study Design
- Enrollment
- 500 participants (estimated)
Arms
- Arm: BioBrace Augment GroupAn anterior cruciate ligament reconstruction is performed and BioBrace is used to augment the tissue graft.
Primary Outcome Measure
Improvement in Function [ Time Frame: 3 years post-op ]
Central Contacts
- Kelley Grynewicz7274574955
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| ConMed | New Haven | Connecticut | 06513 |
Find similar trials in New Haven, CT
By research site
Related Studies
- MRI Evaluation of Graft Maturation Following ACL ReconstructionNot Yet Recruiting · Skye Biologics Holdings, LLC · Sugar Land, Texas